MannKind | 销售和管理费用



Selling And Administration Expenses 更改 日
Adma Biologics USD 24.59M 5.01M 2024-12
Dynavax Technologies USD 106.33M 64.74M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Halozyme Therapeutics USD 42.36M 113K 2025-03
Insmed USD 147.54M 5.03M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
MannKind USD 25.01M 1.04M 2025-03
Merck USD 2.53B 319M 2025-03
Novo Nordisk DKK 16.59B 501M 2024-09
Pfizer USD 3.01B 1.27B 2025-03
Sanofi EUR 2.22B 980M 2025-03
Xencor USD 17.34M 2.42M 2025-03



MannKind 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.